A study on posterior cingulate gyrus glutamate levels in mild cognitive impairment patients using proton magnetic resonance spectroscopy with multi-voxel
Chen Shuangqing, Cai Qing,Shen Yuying, Zhao Zhong, Zhou Hua
Department of Radiology, Suzhou Hospital, Nanjing Medical University, Suzhou 215001, China
Abstract：Objective To explore the diagnosis value of quantitative analysis of glutamate(Glu) with mild cognitive impairment (MCI) by proton magnetic resonance spectroscopy (1H-MRS).Methods According to the clinical diagnosis standard for cognitive function, the study group included 20 patients with mild cognitive impairment (MCI group, 9 males and 11 females) and 20 patients with Alzheimer′s disease (AD group,10 males and 10 females), and the control group used 20 healthy volunteers (NC group, 9 males and 11 females). All of the patients and volunteers were scanned by multi voxel 1H-MRS using rapid acquisition with relaxation enhancement (RARE) and point-resolved spectroscopy (PRESS) pulse sequence. The levels of the Glu and Cr were measured in the posterior cingulate gyrus, hippocampus and the frontal gyms cortex automatically by the NUTS-NMR Utility Transform Software. The ratios of Glu/Cr were calculated and compared among the groups. Comparisons of the cognitive function and the 1H-MRS indexes among MCI, AD and NC group were conducted by single factor analysis of variance (one-way ANOVA), between two groups significantly compared with minimal difference method (LSD).Results Gender,age,and the fixed number of year of the education comparison between each group had no statistical difference(P>0.05). MMSE detection showed that cognitive function in the MCI group was lower than that in the NC group, and difference was statistically significant (t=0.427,P<0.05).However,there was significant difference in cognitive function between AD and MCI groups (t=0.366,P<0.05). According to 1H-MRS, Glu/Cr ratios of the posterior cingulate gyri region in AD (0.37±0.03) and MCI (0.30±0.03) groups were significantly decline compared with NC group(0.42±0.03), and different had statistical difference (t=0.271 and 0.652,P<0.05). However, there were no significant difference for Glu/Cr ratios of the hippocampus between MCI (0.40±0.03) and NC (0.41±0.03) groups (t=0.054,P>0.05), but the Glu/Cr ratios of the hippocampus region in AD (0.32±0.03) and NC groups were significantly different 公式,P<0.05). There were no significant changes in Glu/Cr ratios among AD, MCI and NC groups (0.41±0.03, 0.43±0.03 and 0.43±0.03).Conclusion In 1H-MRS test, Glu may be an effective biochemical index of the diagnosis of MCI. 1H-MRS quantitative analysis provides the important basis for the early diagnosis of MCI.
[1]Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment[J]. Arch Neurol,2001,58(12): 1985-1992. [2]Yesavage JA, O′Hara R, Kraemer H, et al. Modeling the prevalence and incidence of Alzheimer′s disease and mild cognitive impairment[J]. J Psychiatr Res,2002,36(5): 281-286. [3]Rami L, Comez-Anson Bosch B,Bosch B,et al. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease[J]. Dement Geriatr Cogn Disord, 2007, 24(4): 274-279. [4]Wang Z, Zhao C, Yu L, et al. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease[J]. Acta Radiol, 2009,50(3): 312-319. [5]Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome[J]. Arch Neurol, 1999,56(6): 760. [6]郭起浩, 洪震. 轻度认知损害的诊断与评估[J]. 中华神经科杂志, 2010, 43(3): 169-170. [7]Petersen RC. Mild cognitive impairment:current research and clinical implications[J].Semin Neurol,2007,27(1):22-31. [8]Petersen RC.Mild cogntive impairment transition between aging and Alzheimer′s disease[J].Neurologia,2000,15(3):93-101. [9]Kantarci K, Weigand SD, Petersen PC, et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease[J]. Neurobiol Aging, 2007, 28(9): 1330-1339. [10] Alvarez EO, Ruarte MB. Glutamic acid and histamine-sensitive neurons in the ventral hippocampus and the basolateral amygdala of the rat: functional interaction on memory and learning processes[J]. Behav Brain Res, 2004, 152(2): 209-219. [11]Hertz L, Dringen R, Schousboe A,et al. Astrocytes: Glutamate producers for neurons[J]. Neurosci Res,1999, 57(4): 417-428. [12]Shen J, Rothman DL. Magnetic resonance spectroscopic approaches to studying neuronal: glial interactions[J]. Biol Psychiatry, 2002, 52(7): 694-700. [13]Rupsingh R, Borrie, M, Smith M, et al. Reduced hippocampal glutamate in Alzheimer disease[J]. Neurobiol Aging, 2011, 32(5):802-810.
2013, Vol. 1 
